Sign In
Buy LPCN
$2.12
+0.0100 (+0.474%)
At Close: Jul 31, 2026
Lipocine: Imminent Catalysts In NASH And Oral Testosterone Replacement Therapy Make For A Strong Buy
02:19pm, Monday, 14'th Dec 2020
LPCN's long road to market for its oral testosterone pill has been bumpy; however, the FDA just gave TLANDO tentative approval.
Lipocine Announces Tentative Approval of TLANDO™
08:49pm, Tuesday, 08'th Dec 2020
SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food a
Lipocine Announces Deletion of Unauthorized Changes to Company's Website
08:40pm, Tuesday, 08'th Dec 2020
SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that an independent
Lipocine Provides New Regulatory Update on TLANDO™
05:45pm, Friday, 04'th Dec 2020
SALT LAKE CITY, Dec. 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food a
Here is What Hedge Funds Think About Lipocine Inc (LPCN)
08:04pm, Thursday, 26'th Nov 2020
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and
Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection
11:50am, Friday, 06'th Nov 2020
Lipocine is about to report data from its clinical study on whether TLANDO can restore testosterone levels in hypogonadal men without the dose titration requirement on November 9, 2020. Low baseline t
Fortress Reports Positive Data And Other News: The Good, Bad And Ugly Of Biopharma
12:29am, Monday, 31'st Aug 2020
Fortress Biotech reports positive data from CUTX-101. Lipocine suffers setback on Tlando front.
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
08:12am, Saturday, 22'nd Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Lipocine’s Tlando Drug Could Push Shares Higher, Says Analyst
11:56pm, Wednesday, 19'th Aug 2020
When it comes to biotechs, all it takes is a single spark to ignite the flame. For Lipocine (LPCN), which is focused on metabolic and endocrine disorders, this spark could be a fast-approach regulator
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
12:00am, Friday, 31'st Jul 2020
July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP) cellulite treatment, Osmotica Pharmaceuticals PLC's (NASDAQ: OSMT) eye...
Lipocine (NASDAQ:LPCN) Trading Down 2%
02:54pm, Thursday, 16'th Jul 2020
Lipocine Inc (NASDAQ:LPCN)’s share price traded down 2% during mid-day trading on Tuesday . The company traded as low as $1.21 and last traded at $1.23, 22,086 shares were traded during trading. A d
Lipocine Regains Complinace With Nasdaq Minimum Bid Price Requirement
12:00pm, Monday, 13'th Jul 2020
Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has received a letter from The Nasdaq Stock Market LLC ("
Lipocine Target of Unusually High Options Trading (NASDAQ:LPCN)
01:30am, Wednesday, 24'th Jun 2020
Lipocine Inc (NASDAQ:LPCN) saw unusually large options trading on Tuesday. Stock investors acquired 2,469 call options on the company. This is an increase of 772% compared to the average volume of 283
Last Minute Father's Day magazine sale from $5/yr. - 9to5Toys
06:15pm, Thursday, 18'th Jun 2020
DiscountMags has now kicked off a Last Minute Father's Day magazine sale including Wired, Men’s and Women’s Health, GQ, Esquire, and more.
Hedge Funds Cashing Out Of Lipocine Inc (LPCN)
05:58pm, Thursday, 28'th May 2020
In this article we will check out the progression of hedge fund sentiment towards Lipocine Inc (NASDAQ:LPCN) and determine whether it is a good investment right now. We at Insider Monkey like to exami
